2019
DOI: 10.3389/fpsyt.2019.00067
|View full text |Cite
|
Sign up to set email alerts
|

Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review

Abstract: Background: Clinical and functional outcome improvement in psychotic disorders is a challenge for the investigators. Recent advances offered opportunities for ameliorating the course of the illness during its early stages and for identifying treatment-resistant patients. Patients who had not response to two different antipsychotics, administered at correct doses for a sufficient period, can be operationally considered treatment-resistant. Available evidence suggested that the response's trajectory t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
51
1
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(57 citation statements)
references
References 106 publications
3
51
1
2
Order By: Relevance
“…Other reports have documented the close association between poor adherence and poor outcomes, including relapse, leading to hospital admission and treatment-resistant illness. 32,33 The findings from this sample suggest that most poorly adherent patients experience barriers to adherence in multiple domains, and it seems likely that care approaches will need to target patient attitudes/beliefs about medication, communication with providers to address treatment expectations and discussions regarding side-effects, and managing medication in the context of lifestyle and routines.…”
Section: Discussionmentioning
confidence: 99%
“…Other reports have documented the close association between poor adherence and poor outcomes, including relapse, leading to hospital admission and treatment-resistant illness. 32,33 The findings from this sample suggest that most poorly adherent patients experience barriers to adherence in multiple domains, and it seems likely that care approaches will need to target patient attitudes/beliefs about medication, communication with providers to address treatment expectations and discussions regarding side-effects, and managing medication in the context of lifestyle and routines.…”
Section: Discussionmentioning
confidence: 99%
“…They may have treatment-resistant psychosis or have experienced adverse events with prior treatments, or for other reasons, were resistant to discussing compliance. 26 , 34 , 35 With a relatively short study period, understanding the course of disease for each patient is limited. However, most patients had baseline BH-related claims for ambulatory care, and nearly half for ED or inpatient care.…”
Section: Discussionmentioning
confidence: 99%
“…The social, clinical, and neurocognitive characteristics have also been examined in detail [10, 11], especially to explore the factors predictive of treatment resistance during FEPs, including negative symptoms, comorbid substance use, and “lower premorbid functioning” [12].…”
Section: Introductionmentioning
confidence: 99%